Skip to main content
INIS
OTC Industrial Applications And Services

Radnostix Q2 Loss Widens to $882K; Revenue Down 27% on Product Recalls

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.065
Mkt Cap
$34.182M
52W Low
$0.045
52W High
$0.11
52W Position info
43% above low
Off High info
41% below high
Rel. Volume
Market data snapshot near publication time

INIS sits 43% above its 52-week low of $0.045.

Summary

Radnostix's Q2 2026 net loss widened to $882K as revenue dropped 27% due to product recalls. The company also terminated a $12.5M asset sale and added $500K in related-party debt.


Key Events · Earnings and Guidance · INIS

  • Q2 Net Loss Widens

    Net loss of $881,997 for Q2 2026, up from $160,785 in Q2 2025. Six-month net loss of $2,230,083 versus $273,479 a year ago.

  • Revenue Down 27%

    Q2 revenue of $2,671,785, down 27% from $3,655,320. The decline was driven by two voluntary product recalls that caused an estimated $850,000 in lost sales.

  • DUF6 Asset Sale Terminated

    The company mutually terminated the DUF6 asset sale with American Fuel Resources, which would have provided $12.5 million in proceeds. The company is now seeking to monetize the NRC license.

  • New Related-Party Debt

    Borrowed $500,000 from Kershner Grosso & Co., managed by the Chairman, with a 5% interest rate and conversion rights at $0.07 per share.


Analysis · INIS · Industrial Applications And Services

Radnostix reported a net loss of $881,997 for Q2 2026, a sharp deterioration from the $160,785 loss a year ago. Revenue fell 27% to $2.67 million, driven by two voluntary product recalls in January and February 2026 that cost an estimated $850,000 in lost sales. The company also terminated its DUF6 asset sale, which would have brought in $12.5 million, and took on $500,000 in new debt from a related party. These results confirm the operational and financial strain from the recalls and the failed asset sale, and the company's cash position has declined to $1.2 million.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INIS was trading at $0.06 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $34.2M. The 52-week trading range was $0.05 to $0.11. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INIS - Latest Insights

INIS
Nov 16, 2026, 9:00 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.0479
Real-time Price: $0.0385 info
Change: -$0.0094 (-20%) info
Market Cap: $20.372M info
INIS
Oct 01, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.055
Real-time Price: $0.0385 info
Change: -$0.0165 (-30%) info
Market Cap: $20.372M info
INIS
Jul 02, 2026, 10:48 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.070
Real-time Price: $0.0385 info
Change: -$0.0315 (-45%) info
Market Cap: $20.372M info
INIS
Jul 01, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0714
Real-time Price: $0.0385 info
Change: -$0.0329 (-46%) info
Market Cap: $20.372M info
INIS
Jun 04, 2026, 12:38 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.0789
Real-time Price: $0.0385 info
Change: -$0.0404 (-51%) info
Market Cap: $20.372M info